Abstract

Objective

It is known that coronavirus infectious disease 2019 (COVID-19), patients continue to have symptoms, respiratory system insufficiency and loss of functional status in the post-COVID period after dischargefrom the hospital.

Materials and Methods

A total of 101 patients who werehospitalized in the intensive care unit and who could be questioned for their post-COVID symptoms at the1st and 3rd months after discharge from the hospital were included in this study.

Results

The most frequent symptom observed at the time of discharge was dyspnea (n=89), which has been found to be related to comorbidity, hypoxiaand hypertension. Moreover, it was observed thatat least 1 symptom persisted in 50 patients at the 3rd month of discharge, and the most frequentsymptom was fatigue and forgetfulness.

Conclusion

Taking into account the patients’ risk factors, comorbidities and conditions during the hospitalization process, the process of transition to normal life after discharge can be accelerated with early discharge and more effective rehabilitation according to their functional status. Thus, labor loss can be prevented and costs can be reduced.

Keywords: Prolonged COVID-19, dyspnea, intensive care

References

  1. Halk Sağlığı Genel Müdürlüğü. Genel Bilgiler, Epidemiyoloji ve Tanı Aralık 2020, Ankara. Available at: https://covid19.saglik.gov.tr/TR-66337/genel-bilgiler-epidemiyoloji-ve-tani.html
  2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-33.
  3. Callard F, Perego E. How. Why patients made long COVID. Soc Sci Med. 2021;268:113426.
  4. COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline; Published: December 18 2020.
  5. Mahase E. COVID-19: what do we know about ”long COVID”? BMJ. 2020;370:m2815.
  6. King’s College London. New research identifies those most at risk from ”long COVID. 21 October 2020; 06.12.2020 Available at: http://kcl.ac.uk/news/study identifies-those-most-risk-long-COVID.
  7. Long-term effects of COVID-19. Accessed on: 06.12.2020 Available at: http://cdc.gov/coronavirus/2019-ncov/long-term-effects.htm.
  8. Barman MP, Rahman T, Bora K, Borgohain C. COVID-19 pandemic and its recovery time of patients in India: A pilot study. Diabetes Metab Syndr. 2020;14:1205-11.
  9. Nehme M, Braillard O, Alcoba G, Aebischer Perone S, Courvoisier D, Chappuis F, et al. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Ann Intern Med. 2021;174:723-5.
  10. Bohn MK, Lippi G, Horvath A, Sethi S, Koch D, Ferrari M, et al. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC task force evaluation of the latest evidence. Clin Chem Lab Med. 2020;58:1037-52.
  11. Silva VZMD, Araújo JA Neto, Cipriano G Jr, Pinedo M, Needham DM, Zanni JM, et al. Brazilian version of the Functional Status Score for the ICU: translation and cross-cultural adaptation. Rev Bras Ter Intensiva. 2017;29:34-8.
  12. Keypoints | Evaluating and caring for patients with post-COVID conditions CDC. Available at: https://stacks.cdc.gov/view/cdc/107148
  13. Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, et al. Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID 19. Cardiovasc Res. 2020;116:1688-99. Erratum in: Cardiovasc Res. 2021;117:2394.
  14. Carfì A, Bernabei R, Landi F, For the Gemelli Against COVID. 19 post-acute care study group. Persistent Symptoms Patients After Acute COVID-19. JAMA. 2020;324:603-5.
  15. Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:993-8.
  16. Machado FVC, Meys R, Delbressine JM, Vaes AW, Goërtz YMJ, van Herck M, et al. Construct validity of the post-COVID-19 Functional Status Scale in adult subjects with COVID-19. Health Qual Life Outcomes. 2021;19:40.
  17. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Apache II: a severity of disease classification system. Crit Care Med. 1985;13:818-29.
  18. Ricks E. Critical illness polyneuropathy and myopathy: a review of evidence and the implications for weaning from mechanical ventilation and rehabilitation. Physiotherapy. 2007;93:151-6.

Copyright and license

Copyright © 2024 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite?

1.
Karagülle İV, Gelir İK, Yelken BB. Investigation of the Effect of Laboratory Values of ICU Patients Diagnosed with COVID-19 During Hospitalization on Their Symptoms After Discharge. Turk J Intensive Care. 2024;22(4):289-295. https://doi.org/10.4274/tybd.galenos.2023.03360